Page 171 - FBL AR 2019-20

CORPORATE STATUTORY FINANCIAL
OVERVIEW STATEMENTS STATEMENTS

Notes to the Standalone financial statements for the year ended March 31, 2020

63 The World Health Organisation (WHO) declared Covid-19 to be a global pandemic in March 2020. The lockdown and restrictions imposed
on various activities due to COVID-19 pandemic have posed challenges to the Company.
In Compliance with the directions issued by the Government of India, the Company had suspended operations at two of our
manufacturing locations in Dahej, Gujarat and Kullu, Himachal Pradesh with effect from March 25, 2020 to ensure the safety of our
employees and their families and to contain the spread of COVID-19.
The Company was granted permission by the District Magistrate, to partially run both of our plants, for manufacturing of Essential
Commodities. In view of the same, the Company had resumed partial operations at Kullu plant from April 03, 2020 and Dahej plant from
April 04, 2020.
The Company has adopted work from home policy during the entire duration of lockdown in its corporate office and R&D centre at
Thane since March 16, 2020
As per the current assessment of the situation based on the internal and external information available up to the date of approval of
these standalone financial statements by the Board of Directors, the Company believes that the Impact of Covid-19 on its business,
assets, internal financial controls, profitability and liquidity, both present and future, would be limited and there is no indication of any
material impact on the carrying amounts of property, plant and equipment, investment property, goodwill, other intangible assets,
inventories, trade receivables, investments and other assets. The eventual outcome of the impact of the global health pandemic may
be different from those-estimated as on the date of approval of these standalone financial statements and the Company will closely
monitor any material changes to the economic environment and their impact on its business in the time to come.

64 a) The Board of Directors at their meeting held on June 29, 2020 had approved the standalone financial results of the Company for
the year ended March 31, 2020. Subsequent thereto there have been no events which require adjustment or disclosure in these
standalone financial statements except for disclosure made in footnote to 46D.
b) The Standalone financial statements were approved for issue by the Board of Directors on August 28, 2020.

For and on behalf of the Board of Directors of
Fermenta Biotech Limited (Formerly known as DIL Limited)

Krishna Datla Satish Varma Prashant Nagre
Managing Director Executive Director Chief Executive Officer

Sumesh Gandhi Srikant N. Sharma
Chief Financial Officer Company Secretary
Thane, August 28, 2020

169